v3.26.1
Condensed Interim Consolidated Statements of net Loss and Comprehensive Loss (Unaudited) - CAD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Profit or loss [abstract]        
Revenue $ 868,426 $ 627,920 $ 1,744,170 $ 2,909,754
Cost of sales 344,091 877,007 610,725 1,232,107
Gross profit (loss) 524,335 (249,087) 1,133,444 1,677,647
Selling expenses 105,244 222,913 222,564 372,429
Administrative expenses 1,944,688 792,546 3,729,024 2,088,174
Share-based compensation   (691,924)   (691,924)
Financial expenses 728,574 2,173,311 1,356,884 4,196,101
Research and development costs, net of $8,152 in tax credits for the three-month period ended June 30, 2026, $11,981 for the six-month period ended June 30, 2026  ($(26,358) for the three-month period ended June 30, 2025, $(149) for the six-month period ended June 30, 2025) 327,101 330,241 640,811 536,745
  3,105,607 2,827,086 5,949,283 6,501,525
Loss before other gain (2,581,272) (3,076,173) (4,815,839) (4,823,878)
Other income (expenses):        
Gain / (loss) on debt settlement (110,491) 189,901 (133,965)
Gain / (loss) on write -off of assets (44,245) (44,245)
Gain / (loss) on modification of contract (296,722) (302,146)
    (451,457) 189,901 (480,355)
Loss before income taxes (2,581,272) (3,527,631) (4,625,938) (5,304,233)
Income tax expense        
Income tax   15,319   15,027
Net loss for the period (2,581,272) (3,542,950) (4,625,938) (5,319,261)
Other comprehensive income (expense):        
Foreign exchange difference on translation of foreign operations (803,318) 488,459 (803,318) 488,459
Total comprehensive loss for the period $ (3,384,590) $ (3,054,491) $ (5,429,256) $ (4,830,802)
Loss per share (Note 16)        
Basic and diluted loss per share $ (0.20) $ (15.65) $ (0.35) $ (23.50)
Weighted average number of outstanding common shares 13,084,716 226,335 13,082,205 226,335